Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsLiabilities and Shareholders EquityLong-Term InvestmentsNon-Current AssetsNon-Current DebtOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Retained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Q32 Bio (QTTB) Other Non-Current Liabilities (2023 - 2025)

Historic Other Non-Current Liabilities for Q32 Bio (QTTB) over the last 3 years, with Q3 2025 value amounting to $55.0 million.

  • Q32 Bio's Other Non-Current Liabilities changed 0.0% to $55.0 million in Q3 2025 from the same period last year, while for Sep 2025 it was $55.0 million, marking a year-over-year change of 0.0%. This contributed to the annual value of $55.0 million for FY2024, which is 0.0% changed from last year.
  • Q32 Bio's Other Non-Current Liabilities amounted to $55.0 million in Q3 2025, which was down 0.0% from $55.0 million recorded in Q2 2025.
  • Q32 Bio's Other Non-Current Liabilities' 5-year high stood at $55.1 million during Q1 2024, with a 5-year trough of $55.0 million in Q4 2023.
  • In the last 3 years, Q32 Bio's Other Non-Current Liabilities had a median value of $55.0 million in 2023 and averaged $55.0 million.
  • Its Other Non-Current Liabilities has fluctuated over the past 5 years, first changed by 0.0% in 2024, then fell by 20.5% in 2025.
  • Quarter analysis of 3 years shows Q32 Bio's Other Non-Current Liabilities stood at $55.0 million in 2023, then changed by 0.0% to $55.0 million in 2024, then changed by 0.0% to $55.0 million in 2025.
  • Its Other Non-Current Liabilities was $55.0 million in Q3 2025, compared to $55.0 million in Q2 2025 and $55.0 million in Q1 2025.